Tracked deals
3
3 tracked deals across 2021-2024.
Operating Company
Healthcare
Evergen
Alachua, Florida, United States
Formerly known as Evergen (Formerly RTI Surgical), RTI Surgical, RTI Surgical, Inc.
Evergen is a contract development and manufacturing organization (CDMO) partnering with OEMs to develop customized regenerative solutions in tissue engineering and regenerative medicine. It works across specialized clinical segments including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery.
- Focus Areas
- Tissue engineering, Regenerative biomaterials, Biologics manufacturing
- Website
- evergenbio.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Addon
2 addon · 1 divestiture
Evergen Acquisition Volume by Year
Last 2 years
Supporting Data
Recent Transactions
-
October 7, 2024
- Buyer
- RTI Surgical, Montagu
- Target
- Collagen Solutions
- Industry
- Medical Devices
- Location
- Minnesota, United States
- Type
- Addon
RTI Surgical, a Montagu-backed CDMO, has agreed to acquire Collagen Solutions, a global supplier of engineered medical-grade collagen and xenograft tissue, expanding RTI's soft-tissue biomaterials capabilities. The acquisition broadens RTI's access to high-growth therapeutic areas including cardiac, sports medicine and orthopedics, and plastic and reconstructive surgery; Collagen Solutions is headquartered in Eden Prairie, Minnesota with additional sites in the U.K. and New Zealand.
-
- Buyer
- RTI Surgical, Montagu
- Target
- Cook Biotech Incorporated
- Seller
- Cook Group
- Industry
- Medical Devices
- Location
- Indiana, United States
- Type
- Addon
RTI Surgical, backed by private equity firm Montagu, has agreed to acquire Cook Biotech Incorporated, a West Lafayette, Indiana–based leader in regenerative biomaterials, from Cook Group. The add-on will expand RTI's CDMO capabilities in xenograft and naturally derived bioresorbable materials, reinforcing its presence in soft-tissue clinical segments and enabling broader end-to-end services for customers.
-
- Buyer
- RTI Surgical
- Target
- Optecure (Exactech product)
- Seller
- Exactech
- Industry
- Medical Devices
- Location
- Florida, United States
- Type
- Divestiture
RTI Surgical has entered a long-term strategic agreement with Exactech and acquired Optecure, a 510(k)-cleared demineralized bone matrix product used as a bone graft extender. The product acquisition expands RTI Surgical’s biologic bone substitute portfolio while allowing Exactech to focus on its core joint replacement business.
Related Acquisition Pages
Selling a company? Get in front of buyers like Evergen
Turn tracked acquisition activity into an outreach-ready buyer list.